Gaithersburg-Based NovaVax Initiates Trial For Combination COVID-19 And Flu VaccineThe trial will be conducted in Australia at up to 12 sites and results are expected during the first half of 2022.
Novavax Seeks OK For COVID Vaccine In Needy Countries FirstVaccine maker Novavax announced Thursday it has asked regulators in India, Indonesia and the Philippines to allow emergency use of its COVID-19 vaccine -- offering its shot to some low-income countries before rich ones with ample supplies.
Novavax Announces Promising Late-Stage Covid-19 Vaccine Data, More Than 90% EffectiveNovavax announced late-stage data on Monday showing that their vaccine is more than 90 percent effective against Covid-19 across several variants.
Novavax: Large Study Finds COVID-19 Shot About 90% EffectiveVaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico.
WATCH: Gov. Larry Hogan Tours New Novavax Site In Montgomery CountyGov. Larry Hogan toured the new Novavax Global Headquarters site in Montgomery County, Maryland Thursday morning.
University Of Maryland School Of Medicine Begins Novavax COVID-19 Vaccine Study For Ages 12-17The University of Maryland School of Medicine began the expansion of clinical trials for Novavax COVID-19 vaccine in teenagers aged 12 through 17 this week.
Novavax Announces Early Results Of Combination Flu, COVID-19 VaccineMaryland-based Novavax announced Monday the early data from its combination flu and covid-19 vaccine.
Novavax Expands COVID Vaccine Phase 3 Clinical Trial To Children Ages 12 to 17Novavax will expand its phase 3 clinical trial of its covid-19 vaccine candidate to children ages 12 to 17.
Novavax Trials Highlight Maryland's COVID-Fighting ComplexIn the past year, the company has landed nine contracts to manufacture coronavirus-related products for companies, including manufacturing all or part of vaccines for Johnson & Johnson, Novavax and AstraZeneca plc.
Novavax COVID-19 Vaccine Candidate 96.4% Effective In U.K. Trial, Company SaysNovavax announced Thursday its vaccine candidate proved to be 96.4% effective against mild, moderate and severe cases of COVID-19 in a Phase 3 trial in the United Kingdom.
Novavax Announces Start Of Rolling Review Process For Authorization Of COVID-19 VaccineNovavax announced Thursday the start of the rolling review process for authorization of its COVID-19 vaccine, by multiple regulatory agencies.
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy In UK Phase 3 TrialMaryland-based Novavax announced Thursday its COVID-19 vaccine was 89.3% effective in the UK Phase 3 trial.
Novavax COVID-19 Vaccine Phase 3 Trial To Begin In U.S.Novavax on Monday announced the start of the Phase 3 trial of its Covid-19 vaccine in the United States and Mexico. It is the fifth company to launch a large-scale trial of a coronavirus vaccine in the United States.
Maryland-Based Novavax Says Phase 3 Trial For COVID-19 Vaccine Expected To Begin Soon In US, MexicoThe Maryland-based company said its Phase Three Trial is expected to begin in the U.S. and Mexico in the coming weeks.
Novavax COVID-19 Vaccine Granted Fast Track Designation By FDAA coronavirus vaccine developed in Maryland was given fast track designation by the Food and Drug Administration.